Skip to main content
. 2016 Nov 1;11(3):476–483. doi: 10.1177/1932296816676280

Figure 2.

Figure 2.

Impact of CGM use on glycemic control: trends in A1c according to CGM use over the 6-month study. CGM, continuous glucose monitoring; A1c, hemoglobin A1c. Youth are categorized as follows:

- “minimal users” (n = 32): those who used CGM 0-5 days/week at both 3 and 6 months; mean A1c (%) was 8.1 ± 0.9 at baseline; 7.9 ± 0.9 at 3 months; 8.0 ± 0.9 at 6 months.

- “inconsistent users” (n = 10): those who used CGM 6-7 days/week at either 3 or 6 months; mean A1c (%) was 7.8 ± 1.0 at baseline; 7.7 ± 0.9 at 3 months; 7.7 ± 0.7 at 6 months.

- “consistent users” (n = 19): those who used CGM 6-7 days/week at both 3 and 6 months; mean A1c (%) was 7.8 ± 0.9 at baseline; 7.4 ± 0.7 at 3 months; 7.5 ± 0.6 at 6 months.